Onconic Therapeutics Inc.

This study tests a new drug called JPI-547 combined with bevacizumab in 81 people with ovarian cancer that has come back after prior treatment with platinum chemotherapy and PARP inhibitors. The goal is to find the best dose and see if the combination can delay cancer growth. Par…

This study tests a new drug, JPI-547, combined with the chemotherapy irinotecan for people with advanced stomach cancer that has come back or spread. It is for patients who have already tried at least two other treatments. The goal is to see if the combination is safe and can shr…

This study tests a new medicine called JP-1366 for people with non-erosive gastroesophageal reflux disease (NERD), a type of chronic heartburn where the esophagus looks normal. About 321 adults will take the drug or a placebo to see if it reduces days with heartburn. The goal is …

This study looks at how food and ethnicity (Korean, Caucasian, Chinese) affect the drug JPI-547 in healthy men aged 19-50. Participants take one dose and have blood tests and safety checks. The goal is to gather information, not to treat any disease.